Tarun katheriya | Stem Cell Research | Research Excellence Award

Published on by Cell Biologist

Dr. Tarun katheriya | Stem Cell Research | Research Excellence Award

IIT BHU Varanasi | India

Tarun Katheriya is a physicist with extensive expertise in the synthesis, characterization, and analysis of advanced functional materials, particularly negative-permittivity ceramics, perovskites, and multifunctional composites for electromagnetic interference (EMI) shielding and wearable electronics. His Ph.D. research focused on developing epsilon-negative materials, including layered perovskites and glass-ceramics, with tunable dielectric and conductive properties. He has synthesized a variety of electro-ceramics and glass-ceramics, exploring their dielectric behavior through classical and modified Drude models, and demonstrated their EMI shielding effectiveness. Notably, his work includes investigating coil-less inductive properties in conducting ceramics and studying the electrochemical performance of these materials. Katheriya has contributed to understanding the correlation between conductivity and permittivity in doped perovskites, as well as high-temperature dielectric properties in layered oxides. His research integrates experimental synthesis with theoretical modeling, advanced characterization techniques such as XRD, SEM, impedance analysis, and vector network analysis, and simulation tools including FullProf, Zview, and Gaussian. His published work highlights innovations in metal-free nanocomposites, negative-permittivity behavior, and multifunctional EMI shielding, positioning him at the forefront of materials development for next-generation electronic applications.

Profiles: Google Scholar | Scopus | Orcid

Featured Publications: 

  1. Katheriya, T., Pandey, S., & Upadhyay, S. (2025). New frontiers in ceramic composites: Tunable electromagnetic interference shielding by realizing negative permittivity in SnO₂/LaNiO₃ nanocomposites. Journal of Materials Chemistry C.

  2. Katheriya, T., Nirala, G., & Upadhyay, S. (2025). Study of negative permittivity in nanosized LaNiO₃ for electromagnetic interference shielding: A modified Drude model approach. ACS Applied Electronic Materials.

  3. Katheriya, T., Nirala, G., & Upadhyay, S. (2024). Establishing the correlation of negative permittivity and AC conductivity of La₂₋ₓSrₓNiO₄ (x = 0, 0.1, 0.3, 1.0) for microwave shielding applications. Journal of Materials Chemistry C, 12(23), 8473–8484.

  4. Katheriya, T., & Upadhyay, S. (2023). High-temperature study of dielectric and electrical conduction behavior of La₂NiO₄. Physica Scripta, 98(10), 105969.

  5. Verma, H., Mittal, A., Kumar, P., Katheriya, T., Bhattacharya, B., & Upadhyay, S. (2025). Enhanced supercapacitor performance of rGO-modified LaFeO₃ perovskite: Experimental and DFT insights. Materials Chemistry and Physics, 131771.

  1. Nirala, G., Katheriya, T., Yadav, D., Verma, H., & Upadhyay, S. (2023). The evolution of coil-less inductive behavior in La-doped Sr₂MnO₄. Emergent Materials, 6(6), 1951–1962. https://doi.org/[DOI if available]Nirala, G., Yadav, D., Katheriya, T., & Upadhyay, S. (2022). Temperature-dependent negative permittivity in solid solutions Sr₂Mn₁₋ₓSnₓO₄ (x = 0, 0.3, 0.5). Journal of the European Ceramic Society, 42(2), 453–461.

  2. Nirala, G., Katheriya, T., Yadav, D., Pandey, S., & Upadhyay, S. (2022). Effect of Nb doping on epsilon negative behaviour of Sr₂MnO₄. Journal of Materials Science, 57(33), 15862–15875.

  3. Mishra, R. K., Avinashi, S. K., Kumari, S., Nain, R., Katheriya, T., Dwivedi, R. K., … Gautam, C. (2024). Synergistic doping effect of La₂O₃ on BaO–TiO₂–SiO₂ glass-ceramics: Evolution of physical, structural, morphological, and dielectric behaviour for electronics applications. Journal of Alloys and Compounds, 990, 174354.

Tong Ming Liu | Stem Cell Research | Best Researcher Award

Published on by Cell Biologist

Dr. Tong Ming Liu |  Stem Cell Research | Best Researcher Award

Institute of Molecular and Cell Biology | Singapore

Dr. Tong Ming Liu’s research focuses on advancing gene and cell therapy through innovative studies on human mesenchymal stem cells (hMSCs) and induced pluripotent stem cells (iPSCs). His work explores the mechanisms governing mesenchymal stem cell stemness, potency, and ageing, with the goal of improving the therapeutic efficacy and manufacturing quality of MSC-based treatments. A central aspect of his research is identifying and characterizing critical quality attributes (CQAs) in MSC manufacturing to ensure consistent and safe clinical applications. Dr. Liu also investigates disease modeling of bone and cartilage disorders using iPSC-derived MSCs to facilitate drug screening and gene correction strategies. His recent projects include the development of optimized media for iPSC, iPSC-MSC, and MSC culture, as well as identifying novel biomarkers to select high-quality MSCs for regenerative medicine. Through his studies, he aims to enhance the scalability, functionality, and translational potential of stem cell therapies. His findings have been recognized in scientific forums such as the EVANTICA Symposium and Singapore Cell and Gene Therapy Conference, underscoring his contribution to the development of efficient MSC-derived extracellular vesicle (MSC-EV) optimization and regenerative therapy innovations.

Profiles: Google Scholar | Scopus | Orcid

Featured Publications:

Liu, T. M.*, Tew, W., Yang, Z., Lim, B., Hui, J. H. P., Lee, E. H., Loh, Y.-H., & Cool, S. (2025). Understanding the molecular basis of mesenchymal stem cell stemness: Implications for clinical applications. Cell Death & Disease, 16(1), 778.

Liu, T. M.* (2025). MSC-EVs: Pioneering the next generation of biomedical applications. World Journal of Stem Cells, 17(6), 108197.

Liu, T. M.*, & Wu, Y. (2023). Advancing gene and cell therapy using human mesenchymal stem cells. Frontiers in Cell and Developmental Biology, 11, 1294460.

Shou, Y., Liu, L., Le, Z., Lee, K. L., Li, X., Koh, D. Z., Wang, Y., Liu, T. M., Yang, Z., Lim, C. T., Cheung, C., & Tay, A. (2023). Mechano-responsive hydrogel for directing stem cell manufacturing and therapy. Bioactive Materials, 24, 387–400.

Liu, T. M.* (2021). Application of mesenchymal stem cells derived from human pluripotent stem cells in regenerative medicine. World Journal of Stem Cells, 13(12), 1826–1844.

Srinivasan, A., Sathiyanathan, P., Yin, L., Liu, T. M., Lam, A., Ravikumar, M., Smith, R. A. A., Loh, H. P., Zhang, Y., Ling, L., Ng, S. K., Yang, Y. S., Lezhava, A., Hui, J., Oh, S., & Cool, S. M. (2022). Strategies to enhance immunomodulatory properties and reduce heterogeneity in mesenchymal stromal cells during ex vivo expansion. Cytotherapy, 24(5), 456–472.

Liu, T. M.*, Yildirim, E. D., Li, P., Fang, H. T., Denslin, V., Kumar, V., Loh, Y.-H., Lee, E. H., Cool, S. M., Teh, B. T., Hui, J. H., Lim, B., & Shyh-Chang, N. (2020). Ascorbate and iron are required for the specification and long-term self-renewal of human skeletal mesenchymal stromal cells. Stem Cell Reports, 14(2), 210–225.

Sedigheh Gharbi | Stem Cell Research | Best Researcher Award

Published on by Cell Biologist

Dr. Sedigheh Gharbi | Stem Cell Research | Best Researcher Award

Dr. Sedigheh Gharbi | Shahid Bahonar University of Kerman, Kerman, Iran | Iran

Assistant Prof. Dr. Sedigheh Gharbi is a dedicated Iranian biologist. She is currently an Assistant Professor at Shahid Bahonar University of Kerman, specializing in molecular biology with a strong focus on non-coding RNAs and their roles in cancer and cardiac regeneration. With over a decade of academic and research experience, Dr. Gharbi has contributed extensively to understanding microRNAs and long non-coding RNAs in disease mechanisms. She is recognized for her work on cardiomyocyte regeneration, cancer biology, and novel RNA regulatory networks. Dr. Gharbi has published numerous peer-reviewed articles, demonstrating her commitment to advancing biomedical research. Her research aims to translate molecular findings into potential therapeutic strategies, especially in oncology and regenerative medicine. She is also known for mentoring students and collaborating internationally to foster innovation in life sciences.

Publication Profile: 

Google Scholar

Education:

Dr. Sedigheh Gharbi completed her PhD in Molecular Biology at Tarbiat Modares University, Tehran. Her doctoral thesis focused on the microRNA expression profile alterations in serum and urine of sulfur mustard victims, under the supervision of Prof. Seyyed Javad Mowla. This work laid the foundation for her expertise in microRNAs and their diagnostic potential in toxicology and disease. Before her PhD, she earned a Master of Science degree from the University of Isfahan, where she conducted research on the mutational screening of the PIK3CA gene in breast cancer patients under Prof. Manoochehr Tavassoli. This early work sparked her interest in cancer genetics and molecular markers. Her education combined advanced molecular techniques with applied biomedical research, equipping her with the skills necessary for innovative studies in RNA biology and its implications in human diseases.

Experienc:

Since 2014, Dr. Gharbi has served as an Assistant Professor at Shahid Bahonar University of Kerman, where she lectures and leads research in molecular biology and cancer genetics. Her academic career is marked by active involvement in teaching, supervising graduate students, and securing research projects. She has a proven record in managing interdisciplinary studies focused on cardiomyocyte regeneration and RNA biology. Dr. Gharbi’s research experience spans molecular profiling of cancer biomarkers, non-coding RNA regulatory networks, and nanotechnology applications in drug delivery. She has collaborated with multiple research teams nationally and internationally, contributing to both fundamental science and translational medicine. Her role involves experimental design, bioinformatics analysis, and dissemination of findings through scientific publications and conferences. Dr. Gharbi’s experience in mentoring young scientists and publishing extensively positions her as a leader in her field.

Research Focus:

Dr. Gharbi’s primary research focus lies in the regulatory roles of non-coding RNAs—especially microRNAs (miRNAs) and long non-coding RNAs (lncRNAs)—in disease pathogenesis and therapy. She investigates cardiomyocyte regeneration by exploring how lncRNAs influence cell cycle progression, aiming to improve heart repair after injury. In oncology, her research centers on the regulatory structure of E-cadherin and the involvement of non-coding RNAs in cancer progression and management. Additionally, Dr. Gharbi is dedicated to identifying novel miRNAs and elucidating their functions in cellular processes like apoptosis and proliferation. Her work integrates molecular biology techniques with bioinformatics to uncover RNA-based biomarkers and therapeutic targets. The intersection of nanotechnology and RNA therapeutics is another emerging area in her studies, aiming to optimize cancer treatment delivery systems. Overall, her research contributes to understanding complex gene regulation mechanisms and developing RNA-based precision medicine strategies.

Publications Top Notes: 

  1. Mir-542 As A Potential and Promising Therapeutic Target For HPV-Positive Cervical Cancers

  2. CircPAN3/miR-221/PTEN Axis and Apoptosis in Myocardial Infarction: Quercetin’s Regulatory Effects

  3. Controlled cytotoxicity of Ag-GO nanocomposite biosynthesized using black peel pomegranate extract against MCF-7 cell line

  4. Characterization of the first microRNA in human CDH1 that affects cell cycle and apoptosis and indicates breast cancers progression

  5. Curcumin loaded on graphene nanosheets induced cell death in mammospheres from MCF-7 and primary breast tumor cells

  6. Bioinformatics Prediction of microRNAs Regulating Epithelial-to-Mesenchymal Transition in Cancer Cells

  7. Secondary toxic effect of graphene oxide and graphene quantum dots alters the expression of miR-21 and miR-29a in human cell lines

  8. Statins: Complex outcomes but increasingly helpful treatment options for patients

  9. Synthesis and characterization of d10 transition metal complexes in bulk and nano scales: DNA binding, molecular docking and anticancer activity against MCF-7 cell line

  10.  Quantification of circulating miR-517c-3p and miR-210-3p levels in preeclampsia

Conclusion:

In conclusion, Assistant Prof. Dr. Sedigheh Gharbi is highly suitable for the Best Researcher Award based on her consistent track record of innovative, impactful research and academic contributions. Her focus on molecular biology, especially the regulatory roles of non-coding RNAs in cancer and cardiac regeneration, addresses some of the most challenging issues in contemporary biomedical science. Her extensive publication record in reputable journals reflects the quality and significance of her work. While there are opportunities for further enhancing her international collaborations, funding portfolio, and translational efforts, her current achievements already mark her as a leading researcher with great potential for continued contributions. Awarding her the Best Researcher Award would recognize her scientific excellence and encourage further advancements in her promising research career.

 

Liren Qian | Stem cell transplantation | Best Researcher Award

Published on by Cell Biologist

Prof. Dr. Liren Qian | Stem cell transplantation | Best Researcher Award

Prof. Dr. Liren Qian , Chinese PLA General Hospital , China

Dr. Liren Qian, M.D., Ph.D., is a renowned hematologist with extensive experience in both clinical practice and academic research. He currently serves as Vice Director of the Senior Department of Hematology at the Fifth Medical Center, Chinese PLA General Hospital, Beijing, China. With his clinical expertise, Dr. Qian specializes in all hematologic subspecialties and is dedicated to the advancement of hematopoietic stem cell transplantation and radiation medicine. He is also a prominent academic editor for several journals, including Stem Cells International and Frontiers in Oncology. Dr. Qian has made significant contributions to the scientific community, particularly in oxidative stress, hematopoietic stem cell transplantation, and chronic graft-versus-host disease. With a career spanning over a decade, Dr. Qian is widely respected for his work in both clinical and research settings.

Publication Profile:

Orcid

Strengths for the Award:

Dr. Liren Qian, M.D., Ph.D., is an esteemed figure in the field of hematology, with extensive expertise in hematologic diseases and stem cell transplantation. His commitment to both clinical care and research, demonstrated by his current leadership role as Vice Director at the Senior Department of Hematology, Chinese PLA General Hospital, showcases his proficiency in managing complex hematologic conditions. As an active academic editor for prestigious journals such as Stem Cells International and Frontiers in Oncology, Dr. Qian also contributes significantly to the scientific community. His consistent involvement in cutting-edge research, reflected in over 40 peer-reviewed publications, primarily focusing on hematopoietic stem cell transplantation, graft-versus-host disease, and oxidative stress in blood disorders, makes him a standout candidate for the Best Researcher Award.

Areas for Improvement:

While Dr. Qian’s research contributions and clinical accomplishments are substantial, there are opportunities for enhancing the impact of his work in terms of global collaboration. Expanding his research into more interdisciplinary areas, particularly in personalized medicine and genetic therapies, could further enrich his contributions to the field. Additionally, greater outreach in terms of mentoring young researchers and expanding his educational programs could enhance his influence within the medical community.

Education:

Dr. Liren Qian earned his M.D. and Ph.D. in Medicine, specializing in hematology, from prestigious institutions in China. Throughout his educational journey, he focused on advancing his knowledge in hematopoietic stem cell transplantation, radiation medicine, and oxidative stress. His rigorous academic training was complemented by hands-on clinical experience, leading to his recognition as a leader in hematology. During his doctoral studies, Dr. Qian focused on the pathophysiology of hematological disorders and innovative treatments, which has influenced his research trajectory. Over the years, Dr. Qian has expanded his expertise through continuous education and involvement in international academic collaborations. His commitment to medical education is evident in his role as a Master’s degree tutor for medical students and his involvement in training resident doctors and interns.

Experience:

Dr. Liren Qian has a distinguished career in hematology, with experience in both clinical and research domains. He has served as Vice Director of the Senior Department of Hematology at the Fifth Medical Center of the Chinese PLA General Hospital since 2021, overseeing both inpatient and outpatient care in all hematologic subspecialties. Prior to this, Dr. Qian was an Associate Chief Physician, Associate Professor, and Master’s degree tutor, where he played a key role in the implementation of experimental research and clinical trials. His experience also includes serving as an attending physician and as the Secretary of Medical Education, where he developed training programs for residents and interns. Dr. Qian’s extensive work in managing hematological conditions and his contributions to clinical trials have established him as a leading expert in hematology, particularly in stem cell transplantation and radiation-induced hematological diseases.

Awards and Honors:

Dr. Liren Qian has received numerous prestigious awards in recognition of his contributions to medicine and research. In 2019, he was honored with the Innovation Talent Project’s Young Talents Award by the Chinese PLA General Hospital, highlighting his excellence in medical research. In 2018, he received the Military Outstanding Professional and Technical Personnel Award from the Central Military Commission of China, further emphasizing his significant role in advancing medical practices within the military health system. Additionally, Dr. Qian was presented with the Outstanding Medical Service Star Award in 2017 by the Navy General Hospital for his exceptional clinical service. His early accomplishments were acknowledged with the Best in Medical Skills Competition Award (2014) and the Outstanding Medical Worker Award (2013) from the same institution. These accolades reflect his dedication to both the clinical and academic spheres of hematology.

Research Focus:

Dr. Liren Qian’s research is focused on hematopoietic stem cell transplantation, oxidative stress in blood disorders, chronic graft-versus-host disease, and innovative therapies for hematologic malignancies. His work on the therapeutic effects of non-preconditioning allogeneic hematopoietic stem cell transplantation in acute radiation injury has garnered significant attention. Dr. Qian is actively involved in experimental research aiming to improve the outcomes of stem cell transplantation, particularly in the treatment of myelodysplastic syndrome and other hematologic diseases. His research also delves into the role of hydrogen-rich water in ameliorating chronic graft-versus-host disease and the potential of mesenchymal stromal cells in radiation-induced hematological injuries. By focusing on oxidative stress and its impact on hematopoiesis, Dr. Qian seeks to enhance the understanding and treatment of various blood disorders. His innovative approach and dedication to advancing clinical care make his research highly impactful in the field of hematology.

Publications Top Notes:

  • Therapeutic effects of non-preconditioning allogeneic hematopoietic stem cell transplantation on acute radiation injury 🌟
  • Hematopoietic Stem Cell Transplantation in the Management of Myelodysplastic Syndrome 📑
  • Extramedullary Hematopoiesis of the Liver and Spleen 💉
  • Hydrogen‐Rich Water Ameliorates Murine Chronic Graft‐versus‐Host Disease through Antioxidation ⚗️
  • Editorial: Novel Drugs Targeting the Microenvironment and the Epigenetic Changes in Hematopoietic Malignancies 💊
  • Hydrogen in Patients With Corticosteroid-Refractory/Dependent Chronic Graft-Versus-Host-Disease: A Phase 2 Trial 🌱
  • Hematopoietic Stem Cells and Mesenchymal Stromal Cells in Acute Radiation Syndrome 💀
  • Medical Application of Hydrogen in Hematological Diseases 🧬
  • Correction: Genetically enhanced T lymphocytes and the intensive care unit 🏥
  • Genetically enhanced T lymphocytes and the intensive care unit 🔬
  • Protein dysregulation in graft versus host disease ⚖️
  • 8-methoxypsoralen activated by ultraviolet A ameliorates acute graft-versus-host disease in a murine model 🧪
  • Advances in the treatment of newly diagnosed primary central nervous system lymphomas 🧠
  • Detection of ATP Level in CD4+ T Lymphocytes in Hematopoietic Stem Cell Transplantation Recipients 💪
  • The inefficacy of micro-transplantation in relapsed acute lymphocytic leukemia 💔

Conclusion:

Dr. Liren Qian is a highly accomplished hematologist whose work in stem cell therapy, clinical hematology, and transplantation research is exemplary. His dual focus on clinical excellence and scientific inquiry positions him as a leader in his field. With his vast experience and commitment to advancing hematology, he is a highly deserving candidate for the Best Researcher Award.

 

 

 

Chunli Ma | Stem Cell Research | Best Researcher Award

Published on by Cell Biologist

Ms. Chunli Ma | Stem Cell Research | Best Researcher Award

Ms. Chunli Ma  , Shandong Provincial Hospital Affiliated to Shandong First Medical University , China

Chunli Ma is a Master’s student at Shandong Provincial Hospital Affiliated with Shandong First Medical University in China. With a strong background in Optometry and Vision Science, Ma has expanded into Ophthalmology for her graduate studies. She possesses a deep understanding of ocular disorders and the corresponding diagnostic and treatment protocols. She is passionate about cellular and molecular experimentation, specializing in animal models for scientific research. Her expertise extends to experimental techniques that offer innovative solutions for eye injury and healing. Chunli’s work aims to improve corneal repair, reduce scarring, and enhance treatment outcomes for ocular diseases through advanced therapeutic approaches, including stem cell therapy and specialized eye drops.

Publication Profile:

Orcid

Strengths for the Award:

Chunli Ma is a promising researcher with a strong foundation in both clinical ophthalmology and experimental techniques. Her academic background in Optometry and Vision Science, along with her specialized focus on Ophthalmology, positions her as an emerging leader in the field. Ma’s contributions to the understanding and treatment of corneal injuries, particularly her work on exosomes derived from adipose mesenchymal stem cells and antibacterial eyedrops, have significant therapeutic potential. The formulation of exosomes into eyedrops to aid in rapid corneal healing and prevent scarring, along with the development of multifunctional eyedrops for treating bacterial keratitis, showcases her innovative approach to solving complex clinical challenges. Her ability to translate laboratory research into potential clinical applications is commendable. Moreover, her publications in well-regarded journals and ongoing involvement in impactful research add to her eligibility for the Best Researcher Award.

Areas for Improvement:

While Chunli Ma’s work demonstrates great potential, there are areas where she could continue to develop. Expanding her research to a broader range of ocular conditions beyond corneal injury and keratitis could make her work even more influential across various ophthalmic fields. Additionally, seeking more collaborations with interdisciplinary teams, such as those focusing on the genetic and molecular mechanisms of ocular diseases, could provide deeper insights and enhance her ability to tackle more complex issues. Although she has made valuable contributions to scientific publications, continuing to increase the number and impact of her published papers, especially in top-tier journals, will further solidify her reputation in the scientific community. Gaining experience in patent applications and commercialization of her research could also help bridge the gap between laboratory findings and real-world clinical application.

Education:

Chunli Ma completed her undergraduate degree in Optometry and Vision Science, where she gained foundational knowledge in ocular health and vision correction. Building on this, she pursued a Master’s degree in Ophthalmology, which allowed her to specialize in clinical and experimental ophthalmic research. Her academic journey includes hands-on research in cell biology, molecular techniques, and experimental models to address common ocular disorders, particularly in corneal injury repair. Chunli’s academic training has not only refined her diagnostic skills but also equipped her with cutting-edge knowledge in treatment and therapeutic strategies. Her graduate work bridges practical clinical care with advanced research, focusing on cellular regeneration, stem cell treatments, and tissue healing in the eye. This robust academic background underpins her ongoing commitment to advancing ophthalmic medicine through innovative scientific inquiry and applied research in the field of corneal injury and wound healing.

Experience:

Chunli Ma’s academic journey has been bolstered by hands-on experience in both clinical ophthalmology and cellular research. Her work in experimental ophthalmology has focused on the use of adipose mesenchymal stem cells for corneal repair, creating new methodologies for promoting healing and reducing scarring. She has demonstrated expertise in animal model management and experimentation, gaining insights into complex biological processes affecting eye injuries. Ma has contributed to the development of novel treatments, including multifunctional eye drops for both bacterial keratitis and corneal trauma. Her research findings have important clinical implications, directly informing therapeutic strategies for ocular health. Additionally, Ma’s experience includes publishing scientific articles, with a growing portfolio in well-regarded journals. This combination of clinical knowledge, experimental research, and hands-on technique has allowed her to make valuable contributions to ophthalmic science, particularly in terms of innovative solutions for corneal injury and healing.

Research Focus:

Chunli Ma’s research focus is centered on the mechanistic modulation of corneal injury and wound healing. She investigates the potential of stem cell-derived exosomes in promoting the regeneration of corneal tissues, with a particular interest in their role in reducing scarring after trauma. Her work delves into advanced therapeutic applications, such as multifunctional eye drops containing composite antibacterial and healing properties for the treatment of Pseudomonas aeruginosa keratitis. By targeting the underlying molecular and cellular mechanisms of corneal repair, Ma aims to offer innovative solutions for treating corneal injuries and infections. Her research also explores the impact of wound size and location on the prognosis of penetrating ocular injuries, offering a more nuanced approach to patient care. Chunli’s focus on the development of cutting-edge materials and therapies for ophthalmic applications promises significant advances in clinical practice, particularly for patients with challenging corneal conditions.

Publications Top Notes:

  1. Exosomes derived from adipose mesenchymal stem cells promote corneal injury repair and inhibit the formation of scars by anti-apoptosis 📑🧬
  2. Wound size and location affect the prognosis of penetrating ocular injury 👁️‍🗨️🩹
  3. Potential role of ARG1 c.57G > A variant in Argininemia 🔬🧬

Conclusion:

Chunli Ma’s research reflects an excellent blend of clinical expertise and innovative scientific inquiry. Her work has already made notable contributions to improving the treatment of ocular injuries, particularly in corneal healing and bacterial keratitis. With a clear focus on translational research, she has demonstrated the potential for significant advancements in ophthalmic treatments. Given her ongoing dedication to advancing ophthalmology through novel therapeutic approaches, Chunli Ma is undoubtedly a strong candidate for the Best Researcher Award. With continued growth in her research, collaboration efforts, and scholarly output, she has the potential to make even greater strides in the field of ophthalmology and regenerative medicine.